Apple (AAPL) (APPL) tested an app this year to help people with prediabetes manage their food intake and make lifestyle changes, Mark Gurman of Bloomberg reports, citing people with knowledge of the matter. Apple tested the service on select employees earlier this year as part of a broader push into blood-sugar features, sources told Bloomberg. Apple doesn’t have plans to release the app, but may eventually integrate the technology into future health products, including a noninvasive glucose tracker that it’s been developing for more than a decade, adds Gurman. Names in glucose monitoring space fell following the report, including DexCom (DXCM) and Insulet (PODD).
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AAPL:
- Apple beta release has most promised AI features, says Citi
- Judge blocks Tapestry-Capri deal, Centene reports Q3 beat: Morning Buzz
- KeyBanc Downgrades Apple (NASDAQ:AAPL) to Sell amid “Aggressive” Expectations
- Apple downgraded, Tesla upgraded: Wall Street’s top analyst calls
- IDC says Apple returns to top 5 smartphone companies in China